Body Central Corp. (BODY) Reports In-Line Q3 EPS; Comps Down 11.9%; Guides Q4, FY12
Tweet
Share
E-mailGet Alerts BODY Hot Sheet
Join SI Premium – FREE
Body Central Corp. (NASDAQ: BODY) reported Q3 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $67.9 million versus the consensus estimate of $68.98 million.
Comps down 11.9 percent.
Body Central Corp. sees Q4 2012 EPS of $0.19-0.22, versus the consensus of $0.24. Body Central Corp. sees Q4 2012 revenue of $82-84 million, versus the consensus of $81.64 million.
Body Central Corp. sees FY2012 EPS of $0.80-0.83, versus the consensus of $0.84. Body Central Corp. sees FY2012 revenue of $312-314 million, versus the consensus of $312.74 million.
For earnings history and earnings-related data on Body Central Corp. (BODY) click here.
Comps down 11.9 percent.
Body Central Corp. sees Q4 2012 EPS of $0.19-0.22, versus the consensus of $0.24. Body Central Corp. sees Q4 2012 revenue of $82-84 million, versus the consensus of $81.64 million.
Body Central Corp. sees FY2012 EPS of $0.80-0.83, versus the consensus of $0.84. Body Central Corp. sees FY2012 revenue of $312-314 million, versus the consensus of $312.74 million.
For earnings history and earnings-related data on Body Central Corp. (BODY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
